The product could potentially be contaminated with Pseudomonas lactis, although the FDA does not specify how the nasal spray might have come into contact with the bacterium.
The two lots of recalled nasal sprays are expiring in February and August 2027 and have the following lot numbers:
- Lot#: 71409, Expiry: 02/28/2027
- Lot#: 71861, Expiry: 08/31/2027
The recall is not listed on the Walgreens page of recalls, and it’s not clear why. The recall page emphasizes that this is not a comprehensive list of recalls at Walgreens stores, but “specifically identifies Walgreens and Walgreens Boots Alliance-owned brand OTC (over-the-counter) drug and generic merchandise products sold in Walgreens stores.” The saline nasal spray being recalled is a Walgreens-brand over-the-counter product.
According to a vague notice on the FDA website, the recall process for the product was initiated on November 11 and on November 21, the product was given Class II designation, meaning the product “may cause temporary or medically reversible adverse health consequences.”
The recall is only being addressed now because no press release was issued for some unknown reason. Walgreens did not respond to emailed questions Tuesday about why a press release was not issued and why the recall was not listed on its recall page.
The firm involved in the recall was identified as Medical Products Laboratories, Inc. of Philadelphia. Has been done as.
<a href